|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ambros V, Lee RC, Lavanway A, Williams PT
and Jewell D: MicroRNAs and other tiny endogenous RNAs in C.
elegans. Curr Biol. 13:807–818. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin SL, Miller JD and Ying SY: Intronic
microRNA (miRNA). J Biomed Biotechnol. 2006:268182006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hooper CL, Dash PR and Boateng SY: Lipoma
preferred partner is a mechanosensitive protein regulated by nitric
oxide in the heart. FEBS Open Bio. 2:135–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jin L, Hastings NE, Blackman BR and Somlyo
AV: Mechanical properties of the extracellular matrix alter
expression of smooth muscle protein LPP and its partner palladin;
relationship to early atherosclerosis and vascular injury. J Muscle
Res Cell Motil. 30:41–55. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gorenne I, Jin L, Yoshida T, Sanders JM,
Sarembock IJ, Owens GK, Somlyo AP and Somlyo AV: LPP expression
during in vitro smooth muscle differentiation and stent induced
vascular injury. Circ Res. 98:378–385. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142:886–896.e9. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang M, Yao Y, Eades G, Zhang Y and Zhou
Q: MiR-28 regulates Nrf2 expression through a Keap1 independent
mechanism. Breast Cancer Res Treat. 129:983–991. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu J, Liu Y, Sun YN, Li S, Liu XQ, Li J,
Li CM, Tian W, Zhou YT and Shang XM: miR-28-5p involved in
LXR-ABCA1 pathway is increased in the plasma of unstable angina
patients. Heat Lung Circ. 24:724–730. 2015. View Article : Google Scholar
|
|
11
|
Sebolt-Leopold JS and Herrera R: Targeting
the mitogen activated protein kinase cascade to treat cancer. Nat
Rev Cancer. 4:937–947. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pearson G, Robinson F, Beers Gibson T, Xu
BE, Karandikar M, Berman K and Cobb MH: Mitogen-activated protein
(MAP) kinase pathways: Regulation and physiological functions.
Endocr Rev. 22:153–183. 2001.PubMed/NCBI
|
|
13
|
Wang Y: Mitogen-activated protein kinases
in heart development and diseases. Circulation. 116:1413–1423.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou X, Yin Z, Guo X, Hajjar DP and Han J:
Inhibition of ERK1/2 and activation of liver X receptor
synergistically induce macrophage ABCA1 expression and cholesterol
efflux. J Biol Chem. 285:6316–6326. 2010. View Article : Google Scholar :
|
|
15
|
Tall AR: Cholesterol efflux pathways and
other potential mechanisms involved in the athero protective effect
of high density lipoproteins. J Intern Med. 263:256–273. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tall AR, Yvan Charvet L, Terasaka N,
Pagler T and Wang N: HDL, ABC transporters, and cholesterol efflux:
Implications for the treatment of atherosclerosis. Cell Metab.
7:365–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bodzioch M, Orsó E, Klucken J, Langmann T,
Böttcher A, Diederich W, Drobnik W, Barlage S, Büchler C,
Porsch-Ozcürümez M, et al: The gene encoding ATP binding cassette
transporter 1 is mutated in Tangier disease. Nat Genet. 22:347–351.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Brooks Wilson A, Marcil M, Clee SM, Zhang
LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO,
et al: Mutations in ABC1 in Tangier disease and familial high
density lipoprotein deficiency. Nat Genet. 22:336–345. 1999.
View Article : Google Scholar
|
|
19
|
Rust S, Rosier M, Funke H, Real J, Amoura
Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denèfle P and
Assmann G: Tangier disease is caused by mutations in the gene
encoding ATP binding cassette transporter 1. Nat Genet. 22:352–355.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk database: Prediction of possible miRNA binding sites by
“walking” the genes of three genomes. J Biomed Inform. 44:839–847.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Girardot M, Pecquet C, Boukour S, Knoops
L, Ferrant A, Vainchenker W, Giraudier S and Constantinescu SN: miR
28 is a thrombopoietin receptor targeting microRNA detected in a
fraction of myeloproliferative neoplasm patient platelets. Blood.
116:437–445. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Anderson JL, Adams CD, Antman EM, Bridges
CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS,
Levin TN, et al American College of Cardiology; American Heart
Association Task Force on Practice Guidelines (Writing Committee to
Revise the 2002 Guidelines for the Management of Patients With
Unstable Angina/Non-ST-Elevation Myocardial Infarction); American
College of Emergency Physicians; Society for Cardiovascular
Angiography and Interventions; Society of Thoracic Surgeons;
American Association of Cardiovascular and Pulmonary
Rehabilitation; Society for Academic Emergency Medicine: ACC/AHA
2007 guidelines for the management of patients with unstable
angina/non-ST-Elevation myocardial infarction: A report of the
American College of Cardiology/American Heart Association Task
Force on Practice Guidelines (Writing Committee to Revise the 2002
Guidelines for the Management of Patients With Unstable Angina/Non
ST Elevation Myocardial Infarction) developed in collaboration with
the American College of Emergency Physicians, the Society for
Cardiovascular Angiography and Interventions, and the Society of
Thoracic Surgeons endorsed by the American Association of
Cardiovascular and Pulmonary Rehabilitation and the Society for
Academic Emergency Medicine. J Am Coll Cardiol. 50:e1–e157. 2007.
View Article : Google Scholar
|
|
23
|
Mestdagh P, Van Vlierberghe P, De Weer A,
Muth D, Westermann F, Speleman F and Vandesompele J: A novel and
universal method for microRNA RT qPCR data normalization. Genome
Biol. 10:R642009. View Article : Google Scholar
|
|
24
|
Schwindt H, Akasaka T, Zühlke Jenisch R,
Hans V, Schaller C, Klapper W, Dyer MJS, Siebert R and Deckert M:
Chromosomal translocations fusing the BCL6 gene to different
partner loci are recurrent in primary central nervous system
lymphoma and may be associated with aberrant somatic hypermutation
or defective class switch recombination. J Neuropathol Exp Neurol.
65:776–782. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rayner KJ, Sheedy FJ, Esau CC, Hussain FN,
Temel RE, Parathath S, van Gils JM, Rayner AJ, Chang AN, Suarez Y,
et al: Antagonism of miR-33 in mice promotes reverse cholesterol
transport and regression of atherosclerosis. J Clin Invest.
121:2921–2931. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ramirez CM, Dávalos A, Goedeke L, Salerno
AG, Warrier N, Cirera Salinas D, Suárez Y and Fernández Hernando C:
MicroRNA-758 regulates cholesterol efflux through posttranscrip
tional repression of ATP binding cassette transporter A1.
Arterioscler Thromb Vasc Biol. 31:2707–2714. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ramírez CM, Rotllan N, Vlassov AV, Dávalos
A, Li M, Goedeke L, Aranda JF, Cirera Salinas D, Araldi E, Salerno
A, et al: Control of cholesterol metabolism and plasma high–density
lipoprotein levels by microRNA 144. Circ Res. 112:1592–1601. 2013.
View Article : Google Scholar
|
|
28
|
Fernández Hernando C, Ramírez CM, Goedeke
L and Suárez Y: MicroRNAs in metabolic disease. Arterioscler Thromb
Vasc Biol. 33:178–185. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park SY, Lee JH, Ha M, Nam JW and Kim VN:
miR 29 miRNAs activate p53 by targeting p85 α and CDC42. Nat Struct
Mol Biol. 16:23–29. 2009. View Article : Google Scholar
|
|
30
|
Liu P and Wilson MJ: miR-520c and miR-373
upregulate MMP9 expression by targeting mTOR and SIRT1, and
activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in
human fibrosarcoma cells. J Cell Physiol. 227:867–876. 2012.
View Article : Google Scholar
|
|
31
|
Cai J, Guan H, Fang L, Yang Y, Zhu X, Yuan
J, Wu J and Li M: MicroRNA-374a activates Wnt/β-catenin signaling
to promote breast cancer metastasis. J Clin Invest. 123:566–579.
2013.PubMed/NCBI
|
|
32
|
Xiang P, Deng HY, Li K, Huang GY, Chen Y,
Tu L, Ng PC, Pong NH, Zhao H, Zhang L and Sung RY: Dexrazoxane
protects against doxorubicin-induced cardiomyopathy: Upregulation
of Akt and Erk phosphorylation in a rat model. Cancer Chemother
Pharmacol. 63:343–349. 2009. View Article : Google Scholar
|
|
33
|
Dangwal S, Bang C and Thum T: Novel
techniques and targets in cardiovascular microRNA research.
Cardiovasc Res. 93:545–554. 2012. View Article : Google Scholar
|
|
34
|
Joyce CW, Amar MJ, Lambert G, Vaisman BL,
Paigen B, Najib Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT,
Fredrickson DS, et al: The ATP binding cassette transporter A1
(ABCA1) modulates the development of aortic atherosclerosis in
C57BL/6 and apoE knockout mice. Proc Natl Acad Sci USA. 99:407–412.
2002. View Article : Google Scholar
|
|
35
|
Cavelier LB, Qiu Y, Bielicki JK, Afzal V,
Cheng JF and Rubin EM: Regulation and activity of the human ABCA1
gene in transgenic mice. J Biol Chem. 276:18046–18051. 2001.
View Article : Google Scholar : PubMed/NCBI
|
